Please assess the completion status of the following clinical trial:

Trial Title: Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Meets DSM-IV criteria (not including amenorrhea) for AN~* Body mass index (BMI) less than 19 kg/m2 and greater than 14 kg/m2~* Patient (or family if the patient is a minor) refuses hospitalization~* Free of psychotropic medication (4 weeks medication free for fluoxetine and antipsychotic medication; 2 weeks medication free for all others) OR on a stable dose of an SSRI or SNRI (venlafaxine) for 4 weeks before study entry~* Prior treatment of AN~Exclusion Criteria:~* Any medical or psychiatric problem requiring urgent attention and/or any significant comorbid illness not likely to benefit from proposed treatments~* Allergy to olanzapine~* Significant orthostatic high blood pressure~* Recent commencement of psychotherapy in the community~* Diabetes mellitus, with a fasting serum glucose greater than 120 mg/dL or nonfasting serum glucose greater than 140 mg/dL~* Known history of current or past jaundice~* Known history of narrow angle glaucoma~* Active substance abuse or dependence~* Schizophrenia, schizophreniform disorder, or bipolar illness~* Movement disorder or presence of tics~* History of tardive dyskinesia~* History of seizures~* Pregnant

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Participants will take olanzapine.
- 2 (Type: PLACEBO_COMPARATOR): Participants will take matched placebo.

Based on this trial design, predict the completion outcome and termination type (if applicable).